These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23959343)

  • 1. Insulin and glucagon signaling in the central nervous system.
    Filippi BM; Abraham MA; Yue JT; Lam TK
    Rev Endocr Metab Disord; 2013 Dec; 14(4):365-75. PubMed ID: 23959343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age.
    Vogt MC; Brüning JC
    Trends Endocrinol Metab; 2013 Feb; 24(2):76-84. PubMed ID: 23265947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose sensing and the pathogenesis of obesity and type 2 diabetes.
    Thorens B
    Int J Obes (Lond); 2008 Dec; 32 Suppl 6():S62-71. PubMed ID: 19079282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted Leptin Signaling in the Lateral Hypothalamus and Ventral Premammillary Nucleus Alters Insulin and Glucagon Secretion and Protects Against Diet-Induced Obesity.
    Denroche HC; Glavas MM; Tudurí E; Karunakaran S; Quong WL; Philippe M; Britton HM; Clee SM; Kieffer TJ
    Endocrinology; 2016 Jul; 157(7):2671-85. PubMed ID: 27183315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostatic Regulation of Glucose Metabolism by the Central Nervous System.
    Choi JH; Kim MS
    Endocrinol Metab (Seoul); 2022 Feb; 37(1):9-25. PubMed ID: 35255598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS leptin and insulin action in the control of energy homeostasis.
    Belgardt BF; Brüning JC
    Ann N Y Acad Sci; 2010 Nov; 1212():97-113. PubMed ID: 21070248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNS GLP-1 regulation of peripheral glucose homeostasis.
    Sandoval D
    Physiol Behav; 2008 Aug; 94(5):670-4. PubMed ID: 18508100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS-targets in control of energy and glucose homeostasis.
    Kleinridders A; Könner AC; Brüning JC
    Curr Opin Pharmacol; 2009 Dec; 9(6):794-804. PubMed ID: 19884043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New ways in which GLP-1 can regulate glucose homeostasis.
    D'Alessio DA; Sandoval DA; Seeley RJ
    J Clin Invest; 2005 Dec; 115(12):3406-8. PubMed ID: 16322789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central nervous system as a promising target to treat diabetes mellitus.
    Donato J
    Curr Top Med Chem; 2012; 12(19):2070-81. PubMed ID: 23167796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain insulin action in schizophrenia: Something borrowed and something new.
    Agarwal SM; Caravaggio F; Costa-Dookhan KA; Castellani L; Kowalchuk C; Asgariroozbehani R; Graff-Guerrero A; Hahn M
    Neuropharmacology; 2020 Feb; 163():107633. PubMed ID: 31077731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glucose, insulin and glucagon in the regulation of food intake and body weight.
    Grossman SP
    Neurosci Biobehav Rev; 1986; 10(3):295-315. PubMed ID: 3095717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut hormones: a weight off your mind.
    Gardiner JV; Jayasena CN; Bloom SR
    J Neuroendocrinol; 2008 Jun; 20(6):834-41. PubMed ID: 18601707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
    Vahl T; D'Alessio D
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
    Larsen PJ; Vrang N; Tang-Christensen M
    Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6.
    Shirazi R; Palsdottir V; Collander J; Anesten F; Vogel H; Langlet F; Jaschke A; Schürmann A; Prévot V; Shao R; Jansson JO; Skibicka KP
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16199-204. PubMed ID: 24048027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain glucose sensing and neural regulation of insulin and glucagon secretion.
    Thorens B
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():82-8. PubMed ID: 21824260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucagon and glucagon-like peptides the role in control glucose homeostasis. Part I].
    Otto-Buczkowska E
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):215-21. PubMed ID: 22248782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.